Champions Oncology Inc

-0.15 (-2.20%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)90.06M
Current PE224.59
Forward PE 66.6
2yr Forward PE 20.81
See more stats
Estimates Current Quarter
Revenue$13.79 Million
Adjusted EPS$0.01
See more estimates
10-Day MA$6.89
50-Day MA$7.10
200-Day MA$7.80
See more pivots

Champions Oncology Inc Stock, NASDAQ:CSBR

One University Plaza, Suite 307, Hackensack, New Jersey 07601
United States of America
Phone: +1.201.808.8400
Number of Employees: 230


Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.